Specificity: VCY1B siRNA (Human) is a target-specific 19-23 nt siRNA oligo duplexes designed to knock down gene expression. Purity: > 97% Form: Lyophilized
Specificity: VCY siRNA (Human) is a target-specific 19-23 nt siRNA oligo duplexes designed to knock down gene expression. Purity: > 97% Form: Lyophilized
Specificity: VCY shRNA Plasmid (Human) contains 3 different target-specific plasmids each encoding 19-23 nt (plus hairpin) shRNAs designed to knock down gene expression. Each plasmid contains a resistance gene for the selection of cells stably expressing shRNA. Form: Lyophilized
Specificity: VCY1B shRNA Plasmid (Human) contains 3 different target-specific plasmids each encoding 19-23 nt (plus hairpin) shRNAs designed to knock down gene expression. Each plasmid contains a resistance gene for the selection of cells stably expressing shRNA. Form: Lyophilized
Specificity: BPY2B siRNA (Human) is a target-specific 19-23 nt siRNA oligo duplexes designed to knock down gene expression. Purity: > 97% Form: Lyophilized
Specificity: BPY2C siRNA (Human) is a target-specific 19-23 nt siRNA oligo duplexes designed to knock down gene expression. Purity: > 97% Form: Lyophilized
Specificity: BPY2 siRNA (Human) is a target-specific 19-23 nt siRNA oligo duplexes designed to knock down gene expression. Purity: > 97% Form: Lyophilized
Specificity: BPY2 shRNA Plasmid (Human) contains 3 different target-specific plasmids each encoding 19-23 nt (plus hairpin) shRNAs designed to knock down gene expression. Each plasmid contains a resistance gene for the selection of cells stably expressing shRNA. Form: Lyophilized
Specificity: BPY2B shRNA Plasmid (Human) contains 3 different target-specific plasmids each encoding 19-23 nt (plus hairpin) shRNAs designed to knock down gene expression. Each plasmid contains a resistance gene for the selection of cells stably expressing shRNA. Form: Lyophilized
Specificity: BPY2C shRNA Plasmid (Human) contains 3 different target-specific plasmids each encoding 19-23 nt (plus hairpin) shRNAs designed to knock down gene expression. Each plasmid contains a resistance gene for the selection of cells stably expressing shRNA. Form: Lyophilized
Specificity: VCX3B siRNA (Human) is a target-specific 19-23 nt siRNA oligo duplexes designed to knock down gene expression. Purity: > 97% Form: Lyophilized
Specificity: VCX3B shRNA Plasmid (Human) contains 3 different target-specific plasmids each encoding 19-23 nt (plus hairpin) shRNAs designed to knock down gene expression. Each plasmid contains a resistance gene for the selection of cells stably expressing shRNA. Form: Lyophilized
Specificity: VCX2 siRNA (Human) is a target-specific 19-23 nt siRNA oligo duplexes designed to knock down gene expression. Purity: > 97% Form: Lyophilized
Specificity: VCX2 shRNA Plasmid (Human) contains 3 different target-specific plasmids each encoding 19-23 nt (plus hairpin) shRNAs designed to knock down gene expression. Each plasmid contains a resistance gene for the selection of cells stably expressing shRNA. Form: Lyophilized
Specificity: VCX3A siRNA (Human) is a target-specific 19-23 nt siRNA oligo duplexes designed to knock down gene expression. Purity: > 97% Form: Lyophilized
Specificity: VCX siRNA (Human) is a target-specific 19-23 nt siRNA oligo duplexes designed to knock down gene expression. Purity: > 97% Form: Lyophilized
Specificity: VCX shRNA Plasmid (Human) contains 3 different target-specific plasmids each encoding 19-23 nt (plus hairpin) shRNAs designed to knock down gene expression. Each plasmid contains a resistance gene for the selection of cells stably expressing shRNA. Form: Lyophilized
Specificity: VCX3A shRNA Plasmid (Human) contains 3 different target-specific plasmids each encoding 19-23 nt (plus hairpin) shRNAs designed to knock down gene expression. Each plasmid contains a resistance gene for the selection of cells stably expressing shRNA. Form: Lyophilized
We use cookies necessary for the function of our website, to improve your experience, analyse our traffic, and cookies that optimise the performance. To learn more about our cookies, please read our Cookie Notice.